Efficacy and Safety of Intravenous Chimeric Antigen Receptor T-Cell Therapy in Adults with Primary Central Nervous System Lymphoma: A Systematic Review and Meta-Analysis

被引：0
|
作者：
Srisurapanont, Karan [1 ]
Nangsue, Chatchaya [1 ]
Tantiworawit, Adisak [2 ]
机构：
[1] Chiang Mai Univ, Fac Med, Chiang Mai, Thailand
[2] Chiang Mai Univ, Fac Med, Dept Internal Med, Div Hematol, Chiang Mai, Thailand
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-162411
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
627
引用
收藏
页码：9557 / 9558
页数：2
相关论文
共 50 条
  • [21] Chimeric antigen receptor T-cell therapy for mantle cell lymphoma with central nervous system involvement: Progress, but not perfect
    Lewis, Katharine L.
    Cheah, Chan Y.
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 203 (05) : 701 - 703
  • [22] Efficacy and safety of chimeric antigen receptor T cell immunotherapy in B-cell non-Hodgkin lymphoma: a systematic review and meta-analysis
    Wang, Na
    Meng, Yunchong
    Wu, Yaohui
    He, Jing
    Liu, Fang
    IMMUNOTHERAPY, 2021, 13 (04) : 345 - U46
  • [23] Outcomes of patients with secondary central nervous system lymphoma treated with chimeric antigen receptor T-cell therapy: A CIBMTR analysis
    Epperla, Narendranath
    Hashmi, Hamza
    Ahn, Kwang W.
    Allbee-Johnson, Mariam
    Chen, Andy I.
    Wirk, Baldeep
    Kanakry, Jennifer A.
    Lekakis, Lazaros
    Kharfan-Dabaja, Mohamed A.
    Scordo, Michael
    Riedell, Peter A.
    Jain, Tania
    Shadman, Mazyar
    Sauter, Craig
    Hamadani, Mehdi
    Herrera, Alex F.
    Ahmed, Sairah
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (03) : 1202 - 1207
  • [24] Safety and efficacy of chimeric antigen receptor T-cell therapy for acute myeloid leukemia: A subgroup based meta-analysis
    Morsy, Mahmoud M.
    Azzam, Ahmed Y.
    Elamin, Osman
    Elswedy, Adam
    Nashwan, Abdulqadir J.
    LEUKEMIA RESEARCH, 2024, 140
  • [25] Risks and Benefits of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Cancer: A Systematic Review and Meta-Analysis
    Grigor, Emma J. M.
    Fergusson, Dean
    Kekre, Natasha
    Montroy, Joshua
    Atkins, Harold
    Seftel, Matthew D.
    Daugaard, Mads
    Presseau, Justin
    Thavom, Kednapa
    Hutton, Brian
    Holt, Robert A.
    Lalu, Manoj M.
    TRANSFUSION MEDICINE REVIEWS, 2019, 33 (02) : 98 - 110
  • [26] Efficacy of Salvage Treatments in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Including Chimeric Antigen Receptor T-Cell Therapy: A Systematic Review and Meta-Analysis
    Kim, Jinchul
    Cho, Jinhyun
    Yoon, Sang Eun
    Kim, Won Seog
    Kim, Seok Jin
    CANCER RESEARCH AND TREATMENT, 2023, 55 (03): : 1031 - 1047
  • [27] A Review of Chimeric Antigen Receptor T-Cell Therapy for Myeloma and Lymphoma
    Atrash, Shebli
    Moyo, Tamara K.
    ONCOTARGETS AND THERAPY, 2021, 14 : 2185 - 2201
  • [28] T-cell primary central nervous system lymphoma: A systematic literature analysis
    Hung Vo
    Bhatia, Ashmeet
    Lok, Edwin
    Wong, Eric T.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [29] Outcomes of patients with primary central nervous system lymphoma following CD19-targeted chimeric antigen receptor T-cell therapy
    Mercadal, Santiago
    Ahn, Kwang Woo
    Allbee-Johnson, Mariam
    Ganguly, Siddhartha
    Geethakumari, Praveen Ramakrishnan
    Hong, Sanghee
    Malone, Adriana
    Murthy, Hemant
    Pawarode, Attaphol
    Sica, R. Alejandro
    Solh, Melhem
    Ustun, Celalettin
    Shadman, Mazyar
    Sauter, Craig S.
    Hamadani, Mehdi
    Herrera, Alex F.
    Lee, Catherine J.
    HAEMATOLOGICA, 2025, 110 (01) : 218 - 221
  • [30] Efficiency and safety of autologous chimeric antigen receptor T-cells therapy used for patients with lymphoma A systematic review and meta-analysis
    Cao, Genmao
    Lei, Lijian
    Zhu, Xiaolin
    MEDICINE, 2019, 98 (42) : e17506
12345